
Novartis Oncology
UICC Partnerships Programme
-
Vanguard Partners
Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets.
Partnership is at the heart of our strategy
Last update
Wednesday 13 November 2024